Natural Product Drug Discovery Trends Reshaping R&D
Natural product drug discovery trends are redefining how teams prioritize, validate, and advance complex bioactive materials into candidates carefully.
This author has not written his bio yet.
But we are proud to say that GenBio Inc. contributed 19 entries already.
Natural product drug discovery trends are redefining how teams prioritize, validate, and advance complex bioactive materials into candidates carefully.
A disciplined lead prioritization workflow helps natural-product programs convert early activity into reproducible, development-ready candidate decisions.
A disciplined view of emerging natural product modalities, from extracts to characterized candidates, reproducible evidence, and development planning.
Metabolomics vs fractionation: see how profiling and bioactivity-guided isolation provide distinct evidence for early natural-product candidate selection.
Biological extract characterization establishes active constituents, reproducibility, and decision-ready evidence for disciplined candidate selection.
Natural product development planning aligns discovery evidence, reproducibility, candidate selection, and regulatory strategy before capital commitment.
A natural product discovery system turns complex extracts into prioritized, characterized candidates through evidence, reproducibility, and careful planning.
Natural product lead dereplication helps discovery teams identify known compounds early, focus validation resources, and prioritize viable candidates.
Mechanism of action validation connects biological activity to reproducible evidence, guiding candidate selection, IP strategy, and development planning.
Biotech discovery platform due diligence examines evidence quality, reproducibility, IP, and development logic before capital is committed to a program.

© 2022 – GenBio Inc.
